Scientific advances will not move the world closer to achieving global health equity until everyone, everywhere can access them.
This resource provides information about the HIV pipeline and recently approved antiretrovirals (ARVs) for activists working on affordability of, and access to HIV prevention and treatment in low- and middle-income countries (LMIC); it was designed to inform decisions about prioritizing drugs for access strategies and campaigns.